KRAS and colorectal carcinoma: Of significance is the fact that KRAS and BRAF mutations are preferentially found as alternative molecular alterations and thus are not frequently observed in the same tumor suggesting that KRAS and BRAF have distinct roles in the development and progression of CRC [5, 9].